Now based in San Francisco, Cortera Neurotechnologies designs implantable medical devices aimed at revolutionising the diagnosis and treatment of incurable neurological conditions as well as enabling cutting-edge neuroscience research. Cortera is a key contributor to a DARPA program (as part of the Obama BRAIN initiative) aimed at developing neurotechnology as a therapy to treat neuropsychiatric disorders such as major depressive disorder, and post traumatic stress disorder.